Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 29. März 2020
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 5340  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 106785  
   
Impact of Silicone Stent Placement in Symptomatic Airway Obstruction due to Non-Small Cell Lung Cancer - A French Multicenter Randomized Controlled Study: The SPOC Trial.
Respiration
Dutau H, Di Palma F, Thibout Y, Febvre M, Cellerin L, Naudin F, Hermant C, Vallerand H, Lachkar S, Fournier C, Laroumagne S, Quiot JJ, Vergnon JM, SPOC Investigators..
PMID: 32213777 [PubMed - as supplied by publisher]


Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Lancet Oncol
Koller M, Shamieh O, Hjermstad MJ, Hornslien K, Young T, Chalk T, Ioannidis G, Harle A, Johnson CD, Tomaszewski KA, Serpentini S, Pinto M, van der Weijst L, Janssens A, Morag O, Chie WC, Arraras JI, Pompili C, Jungraithmayr W, Hechtner M, Katsochi D, Müller K, Gräfenstein L, Schulz C, Bottomley A, European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group., EORTC Lung Cancer Group., European Society of Thoracic Surgeons..
PMID: 32213338 [PubMed - as supplied by publisher]


UHRF1, a regulator of methylation, as a diagnostic and prognostic marker for lung cancer.
Cancer Invest
Goto D, Komeda K, Uwatoko N, Nakashima M, Koike M, Kawai K, Kodama Y, Miyazawa A, Tanaka I, Hase T, Morise M, Hasegawa Y, Kawabe T, Sato M.
PMID: 32212938 [PubMed - as supplied by publisher]


Candida albicans Beta-Glucan Induce Anti- Cancer Activity of Mesenchymal Stem Cells against Lung Cancer Cell Line: An In-Vitro Experimental Study.
Asian Pac J Cancer Prev
Peymaeei F, Sadeghi F, Safari E, Khorrami S, Falahati M, Roudbar Mohammadi S, Roudbary M.
PMID: 32212815 [PubMed - in process]


Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer.
Int J Clin Exp Pathol
Chen JL, Han HN, Lv XD, Ma H, Wu JN, Chen JR.
PMID: 32211096 [PubMed]


Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA.
Cancer Manag Res
Ge QM, Zou YT, Shi WQ, Zhang YQ, Li B, Min YL, Yuan Q, Shao Y.
PMID: 32210622 [PubMed]


Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Br J Cancer
Gridelli C, Ciuleanu T, Domine M, Szczesna A, Bover I, Cobo M, Kentepozidis N, Zarogoulidis K, Kalofonos C, Kazarnowisz A, Korozan M, de Las Penas R, Majem M, Chella A, Griesinger F, Bournakis E, Sadjadian P, Kotsakis A, Chinet T, Syrigos KN, Correale P, Gallou C, Jamet JM, Vetsika EK, Kosmatopoulos K, Georgoulias V, Vx-001-201 trial team..
PMID: 32210365 [PubMed - as supplied by publisher]


Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial.
Ann Oncol
Paz-Ares L, Spira A, Raben D, Planchard D, Cho BC, Özgüro, Daniel D, Villegas A, Vicente D, Hui R, Murakami S, Spigel D, Senan S, Langer CJ, Boothman AM, Broadhurst H, Wadsworth C, Dennis PA, Antonia SJ, Faivre-Finn C.
PMID: 32209338 [PubMed - as supplied by publisher]


Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report.
Transl Lung Cancer Res
Liu L, Lizaso A, Mao X, Yang N, Zhang Y.
PMID: 32206561 [PubMed]


Frontiers of ctDNA, targeted therapies, and immunotherapy in non-small-cell lung cancer.
Transl Lung Cancer Res
Zhu C, Zhuang W, Chen L, Yang W, Ou WB.
PMID: 32206559 [PubMed]


Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study).
Transl Lung Cancer Res
Fiorelli A, D'Andrilli A, Carlucci A, Vicidomini G, Loizzi D, Ardò NP, Marasco RD, Ventura L, Ampollini L, Carbognani P, Bocchialini G, Lococo F, Paci M, Di Stefano TS, Ardissone F, Gagliasso M, Mendogni P, Rosso L, Mazzucco A, Vanni C, Marinucci BT, Potenza R, Matricardi A, Ragusa M, Tassi V, Anile M, Poggi C, Serra N, Sica A, Nosotti M, Sollitto F, Venuta F, Rendina EA, Puma F, Santini M, LuCiLyS study group..
PMID: 32206557 [PubMed]


Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study.
Transl Lung Cancer Res
Zhang R, Wang G, Lin Y, Wen Y, Huang Z, Zhang X, Yu X, Wang W, Xi K, Cerfolio RJ, D'Journo XB, Ruetzler K, Depypere L, Filosso PL, Zhang L, written on behalf of AME Thoracic Surgery Collaborative Group..
PMID: 32206551 [PubMed]


Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study.
Transl Lung Cancer Res
Kakinuma R, Muramatsu Y, Asamura H, Watanabe SI, Kusumoto M, Tsuchida T, Kaneko M, Tsuta K, Maeshima AM, Ishii G, Nagai K, Yamaji T, Matsuda T, Moriyama N.
PMID: 32206549 [PubMed]


Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non-Small Cell Lung Cancer: A Health Technology Assessment.
Ont Health Technol Assess Ser
Ontario Health (Quality) ..
PMID: 32206157 [PubMed - in process]


Unmet needs and opportunities for improving care for patients with advanced lung cancer on targeted therapies: a qualitative study.
BMJ Open
Al Achkar M, Marchand L, Thompson M, Chow LQM, Revere D, Baldwin LM.
PMID: 32205370 [PubMed - in process]


Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer.
Oncology
Palomar-Abril V, Soria-Comes T, Tarazona Campos S, Martín Ureste M, Giner Bosch V, Maestu Maiques IC.
PMID: 32203963 [PubMed - as supplied by publisher]


Constructing E-Nose Using Metal-Ion Induced Assembly of Graphene Oxide for Diagnosis of Lung Cancer via Exhaled Breath.
ACS Appl Mater Interfaces
Chen Q, Chen Z, Liu D, He Z, Wu J.
PMID: 32203649 [PubMed - as supplied by publisher]


Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study.
Br J Cancer
Jeon KH, Shin DW, Han K, Kim D, Yoo JE, Jeong SM, Cho JH.
PMID: 32203211 [PubMed - as supplied by publisher]


Histopathological Type of Lung Cancer and Underlying Driver Mutations in Patients with Chronic Obstructive Pulmonary Disease (COPD) versus Patients with Asthma and COPD Overlap: A Single-Center Retrospective Study.
Turk Thorac J
Sakai T, Hara J, Yamamura K, Abo M, Okazaki A, Ohkura N, Kasahara K.
PMID: 32202995 [PubMed]


Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose-response studies.
Acta Oncol
Stervik L, Pettersson N, Scherman J, Behrens CF, Ceberg C, Engelholm S, Gunnarsson K, Hallqvist A, Nyman J, Persson GF, Pøhl M, Wahlstedt I, Vogelius IR, Bäck A.
PMID: 32202189 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 106785    Seite 1 von 5340  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

  Zeitfenster  
   

Sky right 1